Methotrexate from Japan
Methotrexate is a folic acid antagonist featuring pteridine heterocyclic rings, used as an antineoplastic and immunosuppressant drug. It qualifies for HTS 2934.99.30.00 as an aromatic heterocyclic drug compound used in rheumatoid arthritis and cancer treatments.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.628.5%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Submit Type II Drug Master Files and bioequivalence data for generic API approval during import clearance
• Provide impurity profiles and chiral purity certificates since it's a single enantiomer drug substance
• Include cytotoxic hazard labeling and UN shipping declarations for safe transport compliance